Jazz Pharmaceuticals (JAZZ) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.40% |
| Dec 31, 2025 | 9.34% |
| Sep 30, 2025 | 8.06% |
| Jun 30, 2025 | 7.60% |
| Mar 31, 2025 | 6.66% |
| Dec 31, 2024 | 5.69% |
| Sep 30, 2024 | 6.38% |
| Jun 30, 2024 | 5.89% |
| Mar 31, 2024 | 8.03% |
| Dec 31, 2023 | -3.27% |
| Sep 30, 2023 | 2.35% |
| Jun 30, 2023 | 4.04% |
| Mar 31, 2023 | 4.93% |
| Dec 31, 2022 | 6.04% |
| Sep 30, 2022 | 6.30% |
| Jun 30, 2022 | 11.88% |
| Mar 31, 2022 | 16.53% |
| Dec 31, 2021 | 19.03% |
| Sep 30, 2021 | 20.61% |
| Jun 30, 2021 | 24.27% |
| Mar 31, 2021 | 7.37% |
| Dec 31, 2020 | 8.38% |
| Sep 30, 2020 | 8.97% |
| Jun 30, 2020 | 9.78% |
| Mar 31, 2020 | 12.69% |
| Dec 31, 2019 | 17.64% |
| Sep 30, 2019 | 23.98% |
| Jun 30, 2019 | 27.02% |
| Mar 31, 2019 | 30.33% |
| Dec 31, 2018 | 69.68% |
| Sep 30, 2018 | 75.02% |
| Jun 30, 2018 | 77.19% |
| Mar 31, 2018 | 87.14% |
| Dec 31, 2017 | 87.80% |
| Sep 30, 2017 | 88.65% |
| Jun 30, 2017 | 96.78% |
| Mar 31, 2017 | 126.18% |
| Dec 31, 2016 | 133.25% |
| Sep 30, 2016 | 154.81% |
| Jun 30, 2016 | 170.37% |
| Dec 31, 2015 | 162.24% |